Skip to content

Post-Pregnancy Cardio Trial

Myocardial Characterization With Magnetic Resonance Imaging in Patients After Preeclampsia (Pilot Study)

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03313063
Acronym
PPC1
Enrollment
47
Registered
2017-10-18
Start date
2017-08-28
Completion date
2018-06-30
Last updated
2018-07-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Preeclampsia

Keywords

magnetic resonance imaging, myocard, preeclampsia

Brief summary

Preeclampsia is a systemic pregnancy disorder and is associated with an increased cardiovascular risk later in life. This study will characterize myocardial tissue in patients after preeclampsia compared to controls and investigate potential functional and structural changes in the heart of preeclamptic women primarily with two methods: cardiovascular magnetic resonance imaging and echocardiography. A comparison between these two methods, where appropriate, is also envisaged.

Interventions

None listed

Sponsors

Charite University, Berlin, Germany
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 50 Years
Healthy volunteers
Yes

Inclusion criteria

* postpartal window: 0.5 - 20 years * cases: diagnosis of preeclampsia during the index pregnancy * controls: age and BMI matched

Exclusion criteria

* metal implants * kidney insufficiency (GFR \< 30 ml/min/) * claustrophobia * contrast medium allergy * current pregnancy/ lactation * chronic hypertension (\> 140/90) * diagnosis of previous cardiovascular disease * body weight over 120 kg * big tattoos in thorax area

Design outcomes

Primary

MeasureTime frameDescription
any structural or functional change of the heart (combined outcome)0.5 - 20 years after deliveryCombined outcome: myocardial fibrosis, edema, fat infiltrates, inflammation, reduced ejection fraction, hypertrophy

Secondary

MeasureTime frame
myocardial edema0.5 - 20 years after delivery
myocardial fat infiltrates0.5 - 20 years after delivery
myocardial fibrosis0.5 - 20 years after delivery
myocardial hypertrophy0.5 - 20 years after delivery
reduced ejection fraction0.5 - 20 years after delivery
myocardial inflammation0.5 - 20 years after delivery

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 20, 2026